Thyroid Cancer and Benign Nodules After Exposure In Utero to Fallout From Chernobyl.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 18 04 2018
accepted: 13 08 2018
pubmed: 18 11 2018
medline: 4 12 2019
entrez: 17 11 2018
Statut: ppublish

Résumé

Children and adolescents exposed to radioactive iodine-131 (I-131) in fallout from the 1986 Chernobyl nuclear accident appear to be at increased risk of thyroid cancer and benign thyroid nodules. The prenatal period is also considered radiosensitive, and the fetal thyroid can absorb I-131 from the maternal circulation. We aimed to estimate the risk of malignant and benign thyroid nodules in individuals exposed prenatally. We studied a cohort of 2582 subjects in Ukraine with estimates of I-131 prenatal thyroid dose (mean = 72.6 mGy), who underwent two standardized thyroid screening examinations. To evaluate the dose-response relationship, we estimated the excess OR (EOR) using logistic regression. Based on a combined total of eight cases diagnosed at screenings from 2003 to 2006 and 2012 to 2015, we found a markedly elevated, albeit not statistically significant, dose-related risk of thyroid cancer (EOR/Gy = 3.91, 95% CI: -1.49, 65.66). At cycle 2 (n = 1,786), there was a strong and significant association between I-131 thyroid dose and screen-detected large benign nodules (≥10 mm) (EOR/Gy = 4.19, 95% CI: 0.68, 11.62; P = 0.009), but no significant increase in risk for small nodules (<10 mm) (EOR/Gy = 0.34, 95% CI: -0.67, 2.24; P = 0.604). The dose effect by nodule size, with I-131 risk for large but not small nodules, is similar to that among exposed children and adolescents in Belarus. Based on a small number of cases, there is also a suggestive effect of I-131 dose on thyroid cancer risk.

Sections du résumé

Background
Children and adolescents exposed to radioactive iodine-131 (I-131) in fallout from the 1986 Chernobyl nuclear accident appear to be at increased risk of thyroid cancer and benign thyroid nodules. The prenatal period is also considered radiosensitive, and the fetal thyroid can absorb I-131 from the maternal circulation.
Objectives
We aimed to estimate the risk of malignant and benign thyroid nodules in individuals exposed prenatally.
Methods
We studied a cohort of 2582 subjects in Ukraine with estimates of I-131 prenatal thyroid dose (mean = 72.6 mGy), who underwent two standardized thyroid screening examinations. To evaluate the dose-response relationship, we estimated the excess OR (EOR) using logistic regression.
Results
Based on a combined total of eight cases diagnosed at screenings from 2003 to 2006 and 2012 to 2015, we found a markedly elevated, albeit not statistically significant, dose-related risk of thyroid cancer (EOR/Gy = 3.91, 95% CI: -1.49, 65.66). At cycle 2 (n = 1,786), there was a strong and significant association between I-131 thyroid dose and screen-detected large benign nodules (≥10 mm) (EOR/Gy = 4.19, 95% CI: 0.68, 11.62; P = 0.009), but no significant increase in risk for small nodules (<10 mm) (EOR/Gy = 0.34, 95% CI: -0.67, 2.24; P = 0.604).
Conclusions
The dose effect by nodule size, with I-131 risk for large but not small nodules, is similar to that among exposed children and adolescents in Belarus. Based on a small number of cases, there is also a suggestive effect of I-131 dose on thyroid cancer risk.

Identifiants

pubmed: 30445441
pii: 5184192
doi: 10.1210/jc.2018-00847
pmc: PMC6456983
doi:

Substances chimiques

Iodine Radioisotopes 0
Iodine-131 0
Radioactive Fallout 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-48

Références

Int J Cancer. 2017 Oct 15;141(8):1585-1588
pubmed: 28662277
Radiat Prot Dosimetry. 2003;105(1-4):265-8
pubmed: 14526968
Thyroid. 1999 Jul;9(7):721-6
pubmed: 10447020
Epidemiology. 2006 Nov;17(6):604-14
pubmed: 17028502
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2207-2217
pubmed: 28368520
Am J Epidemiol. 2008 Feb 1;167(3):305-12
pubmed: 17989057
J Clin Endocrinol Metab. 2001 Jul;86(7):3211-6
pubmed: 11443191
PLoS One. 2015 Oct 14;10(10):e0139826
pubmed: 26465339
N Engl J Med. 2004 Oct 21;351(17):1764-71
pubmed: 15496625
JAMA Intern Med. 2015 Feb;175(2):228-36
pubmed: 25545696
Ann ICRP. 2001;31(1-3):19-515
pubmed: 11730884
J Clin Endocrinol Metab. 2009 Mar;94(3):899-906
pubmed: 19106267
Health Phys. 1996 Apr;70(4):559-62
pubmed: 8617598
J Natl Cancer Inst. 2006 Jul 5;98(13):897-903
pubmed: 16818853
Health Phys. 2011 Jun;100(6):583-93
pubmed: 22004928
Int J Radiat Biol. 2003 May;79(5):293-309
pubmed: 12943238
Nat Commun. 2017 Jul 04;8:16129
pubmed: 28675160
J Nucl Med. 1967 Mar;8(3):157-65
pubmed: 6024129
Health Phys. 2001 Mar;80(3):242-50
pubmed: 11219536
Radiologe. 1995 Mar;35(3):141-7
pubmed: 7761588
J Clin Endocrinol Metab. 2005 Sep;90(9):5009-14
pubmed: 15941865
J Clin Endocrinol Metab. 2008 May;93(5):1641-8
pubmed: 18319305
Br J Cancer. 2011 Jan 4;104(1):181-7
pubmed: 21102590
Radiat Res. 2015 Feb;183(2):159-173
pubmed: 25574587
Environ Health Perspect. 2011 Jul;119(7):933-9
pubmed: 21406336
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Natl Cancer Inst. 2008 Mar 19;100(6):428-36
pubmed: 18334707
PLoS One. 2014 Jan 29;9(1):e85723
pubmed: 24489667
Ann ICRP. 2003;33(1-2):5-206
pubmed: 12963090

Auteurs

Maureen Hatch (M)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Alina V Brenner (AV)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Elizabeth K Cahoon (EK)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Vladimir Drozdovitch (V)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Mark P Little (MP)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Tatiana Bogdanova (T)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Victor Shpak (V)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Elena Bolshova (E)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Galyna Zamotayeva (G)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Galyna Terekhova (G)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Evgeniy Shelkovoy (E)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Viktoria Klochkova (V)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Kiyohiko Mabuchi (K)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Mykola Tronko (M)

Institute of Endocrinology and Metabolism, Kiev, Ukraine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH